首页|Ulster University Reports Findings in Personalized Medicine (Computational appro aches for clinical, genomic and proteomic markers of response to glucagon-like p eptide-1 therapy in type-2 diabetes mellitus: An exploratory analysis with machi ne …)
Ulster University Reports Findings in Personalized Medicine (Computational appro aches for clinical, genomic and proteomic markers of response to glucagon-like p eptide-1 therapy in type-2 diabetes mellitus: An exploratory analysis with machi ne …)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews – New research on Drugs and Therapies - Personalize d Medicine is the subject of a report. Accordingto news reporting originating i n Londonderry, United Kingdom, by NewsRx journalists, research stated,“In 2021, the International Diabetes Federation reported that 537 million people worldwid e are living withdiabetes. While glucagon-like peptide-1 agonists provide signi ficant benefits in diabetes management,approximately 40 % of pati ents do not respond well to this therapy.”
LondonderryUnited KingdomEuropeAlg orithmsBiomarkersCyborgsDiabetes MellitusDiagnostics and ScreeningDrug s and TherapiesEmerging TechnologiesEndocrine System Diseases and ConditionsEndocrinologyGastrointestinal HormonesGenet
NETL
NSTL
